Management of Premature Ventricular Contractions

Initial Assessment and Risk Stratification

The European Society of Cardiology suggests that risk factors for PVC-induced cardiomyopathy include high PVC burden (>10-15% of total heartbeats, with highest risk at >20-24%) 3
The American College of Cardiology recommends considering short coupling interval of PVCs (<300 ms) as a risk factor for PVC-induced cardiomyopathy 3
Wider QRS complexes (>160 ms) are associated with an increased risk of PVC-induced cardiomyopathy, according to the American College of Cardiology 4

The American College of Cardiology recommends beta-blockers as first-line therapy for symptomatic PVCs or PVC-induced cardiomyopathy, followed by catheter ablation if medications are ineffective, not tolerated, or not preferred by the patient 1, 2
The European Heart Journal suggests that lifestyle modifications, such as reducing caffeine, alcohol, and sympathomimetic agents, can be beneficial for patients with PVCs 2
Beta-blockers, such as metoprolol, have shown efficacy in suppressing PVCs, with a strength of evidence rated as high, according to the American College of Cardiology 1

The American College of Cardiology recommends considering catheter ablation for patients with PVC-induced cardiomyopathy, with success rates of up to 80% and low complication rates 6
The European Heart Journal suggests that treatment with catheter ablation can restore normal LV function in up to 82% of patients with PVC-induced cardiomyopathy within 6 months 6
The American College of Cardiology recommends pharmacological treatment with beta-blockers or amiodarone to reduce arrhythmias and improve LV function in patients with PVC-induced cardiomyopathy, with a strength of evidence rated as moderate 6

The European Heart Journal recommends optimizing heart failure medications according to current guidelines for patients with structural heart disease and PVCs 7
The American College of Cardiology suggests considering amiodarone or catheter ablation after the first episode of sustained VT in patients with ICDs and structural heart disease 7
The American College of Cardiology recommends evaluating athletes with multiple PVCs (≥2) on ECG, including ambulatory Holter monitor, echocardiogram, and exercise stress test 4

The American College of Cardiology recommends monitoring PVC burden reduction after initiating therapy and following LV function to document improvement in patients with PVC-induced cardiomyopathy 6
The American College of Cardiology suggests considering alternative medications or proceeding to catheter ablation if initial therapy fails, with a strength of evidence rated as high 1